Amended Statement of Beneficial Ownership (sc 13d/a)
February 20 2014 - 3:23PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of
1934
(Amendment No. 3)*
Lion Biotechnologies, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
37182R102
(CUSIP Number)
Amy Wang, Esq.
Bristol Capital Advisors, LLC
1100 Glendon Ave., Suite 850, Los Angeles, CA
90024
(310) 331-8480
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
December 31, 2013
(Date of Event which Requires Filing of this
Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box.
£
Note
: Schedules filed in paper format shall include a
signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are
to be sent.
*
The remainder of this cover page shall be filled
out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act")
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
CUSIP No. 37182R102
|
|
|
1.
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only).
|
|
|
Bristol Investment Fund, Ltd.
|
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
|
|
|
(b)
|
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Source of Funds (See Instructions)
PF
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
|
|
6.
|
Citizenship or Place of Organization
Cayman Islands
|
|
|
7.
|
Sole Voting Power
3,998,732
|
|
8.
|
Shared Voting Power
|
|
9.
|
Sole Dispositive Power
3,998,732
|
|
10.
|
Shared Dispositive Power
|
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
3,998,732
|
|
|
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
|
|
13.
|
Percent of Class Represented by Amount in Row (11)
21.16%
|
|
|
14.
|
Type of Reporting Person (See Instructions)
CO
|
|
CUSIP No. 37182R102
|
|
|
1.
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only).
|
|
|
Bristol Capital, LLC
|
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
(a)
|
|
|
|
(b)
|
|
|
|
3.
|
SEC Use Only
|
|
|
4.
|
Source of Funds (See Instructions)
SC
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
|
|
6.
|
Citizenship or Place of Organization
Cayman Islands
|
|
|
7.
|
Sole Voting Power
133,532
|
|
8.
|
Shared Voting Power
|
|
9.
|
Sole Dispositive Power
133,532
|
|
10.
|
Shared Dispositive Power
|
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
133,532
|
|
|
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
|
|
13.
|
Percent of Class Represented by Amount in Row (11)
0.707%
|
|
|
14.
|
Type of Reporting Person (See Instructions)
CO
|
|
The following constitutes Amendment No. 3 ("Amendment No. 3")
to the Schedule 13D filed by the undersigned. This Amendment No. 3 amends the Schedule 13D as specifically set forth.
Item 2 is hereby amended and restated as follows:
Item 2. Identity and Background
This statement is filed on behalf of all persons and entities and
participants of Bristol Investment Fund, Ltd., a Cayman Islands exempted company with limited liability (“BIF”) and
Bristol Capital, LLC, a Delaware limited liability company ("BC"). BIF and BC are collectively referred to herein as
the “Reporting Persons.”
BIF is a privately held fund that invests primarily in publicly-traded
companies through the purchase of securities in private placement and/or open market transactions. The address of BIF’s registered
office is Caledonian Trust (Cayman) Limited, 69 Dr. Roy’s Drive, George Town, Grand Cayman, Cayman Islands. Bristol Capital
Advisors, LLC, an entity organized under the laws of the State of Delaware (“BCA”), is the investment advisor to BIF.
Paul Kessler is manager of BCA and as such has voting and dispositive power over the securities held by BIF. BC is a privately
held limited liability company that engages from time to time in investing in publicly-traded companies through the purchase of
securities in private placement and/or open market transactions. The address of BCA's and BC's office is 1100 Glendon Ave., Suite
850, Los Angeles, California 90024. Paul Kessler is the sole manager of BC and therefore has voting and dispositive power over
the securities held by BC.
During the last five years neither the Reporting Persons nor Paul
Kessler have been convicted in a criminal proceeding, nor been a party to a civil proceeding of a judicial or administrative body
of competent jurisdiction, as a result of which it was or is subject to a judgment, decree or final order enjoining future violations
of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect
to such laws.
Item 3 is hereby amended and restated as follows:
Item 3.
Source and Amount of Funds or Other Consideration
The, 3,998,732 Shares held by Bristol Investment Fund, Ltd. ("BIF")
as reported herein represent the post-split equivalent of the shares owned by BIF as reported in Amendment No. 2 to the 13D filed
on August 7 2013. The 133,532 Shares held by Bristol Capital, LLC ("BC") as reported herein represent the post-split
equivalent of the 13,353,215 Shares that were issued pursuant to the Director Stock Award Agreement dated as of July 24, 2013
by and between the Issuer and BC.
Item 5 is hereby amended and restated as follows:
Item 5.
Interest in Securities of the Issuer
(a)
|
|
As of the date of the filing of this Amendment No. 3 to Schedule 13D, (i) Bristol
Investment Fund, Ltd. owns 3,998,732 Shares, which represents approximately 21.16% of the 18,893,211 shares outstanding as of
November 14, 2013, as reported by the Issuer in its 10Q filed on November 14, 2013, and (ii) Bristol Capital, LLC owns 133,532
Shares, which represents approximately 0.707% of the 18,893,211 shares outstanding as of November 14, 2013, as reported by the
Issuer in its 10Q filed on November 14, 2013.
|
(b)
|
|
Paul Kessler, as manager of the investment advisor to Bristol Investment Fund, Ltd.
("BIF") and the manager of Bristol Capital, LLC ("BC"), has power to vote and dispose of the Shares owned
by BIF and BC. Mr. Kessler disclaims beneficial ownership of the Shares owned by BIF. On May 24, 2013, Mr. Kessler was elected
by the Issuer's stockholders to serve on the Issuer's Board of Directors. Mr. Kessler subsequently resigned from the board in
July 2013, as was originally contemplated.
|
(c)
|
|
Other than the shares acquired as described herein, the Reporting Persons have not
purchased or sold any shares of the Issuer's common stock during the last sixty days.
|
(d)
|
|
No person other than the Reporting Persons is known to have the right to receive,
or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
|
Signature
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and correct.
Dated: February 20, 2014
BRISTOL INVESTMENT FUND, LTD.
By: /s/ Paul Kessler